Comparability of tumor marker immunoassays: still an important issue for clinical diagnostics?

Articles in the same Issue

1. Editorial
2. Comparability of tumor marker immunoassays: still an important issue for clinical diagnostics?
3. Review
4. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases
5. Validation and Outcome Studies
6. Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access^® OV Monitor assay on the UniCel^® DxI 800 Immunoassay System
7. Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access^® GI Monitor assay on the UniCel^® DxI 800 Immunoassay System
8. Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access^® BR Monitor assay on the UniCel^® DxI 800 Immunoassay System
9. Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards
10. Multicentre evaluation of a new point-of-care test for the determination of CK-MB in whole blood
11. Down's syndrome screening: population statistic dependency of screening performance
12. General Clinical Chemistry and Laboratory Medicine
13. Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease
14. Role for mitochondrial uncoupling protein-2 (UCP2) in hyperhomocysteinemia and venous thrombosis risk?
15. Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications
16. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease
17. Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism
18. The effect of the mode of delivery on the maternal-neonatal carnitine blood levels and antioxidant status
19. Time to reconsider the clinical value of immunoglobulin G4 to foods?
20. Reference Values
21. Determination of reference intervals for 26 commonly measured biochemical analytes with consideration of long-term within-individual variation
22. Beverage-specific effects of ethanol consumption on its biological markers
23. Limits of preservation of samples for urine strip tests and particle counting
24. Reference ranges and diagnostic thresholds of laboratory markers of cardiac damage and dysfunction in a population of apparently healthy black Africans
25. Letters to the Editor
26. External quality assessment schemes for real-time PCR: a statistical procedure to corrective actions
27. Application of two different microarray-based copy-number detection methodologies – array-comparative genomic hybridization and array-multiplex amplifiable probe hybridization – with identical amplifiable target sequences
28. Criticism to the article: “Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method.” Authors: J.O. Jeppsson et al. Clin Chem Lab Med 2007;45(4):558–562
29. Standardization of carbohydrate-deficient transferrin: reply to the letter by Tagliaro and Bortolotti
30. Comment on: Bellini C, Serra G, Risso D, Mazzella M, Bonioli E. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clin Chem Lab Med 2007;45(11):1549–54
31. Reliability assessment of glucose measurement by HemoCue analyzer in a neonatal intensive care unit: reply to Dr. Joakim Hagvik